Lymphoblastic lymphoma is a cancer of immature lymphocytes, cells of the immune system, called lymphoblasts. It is a form of non-Hodgkin lymphoma. Lymphoblastic lymphoma primarily affects children and accounts for about 35 percent of all non-Hodgkin lymphomas in children.
Lymphoblastic lymphoma treatment at Dana-Farber/Boston Children's
Children with lymphoblastic lymphoma are treated at Dana-Farber/Boston Children's through the Lymphoma Program in our Hematologic Malignancies Center. One of the top pediatric cancer centers worldwide, Dana-Farber/Boston Children’s combines the expertise of a premier cancer center — Dana-Farber Cancer Institute — and a world-class children’s hospital — Boston Children’s Hospital — to provide internationally-renowned care for children with cancer.
Practitioners Who Specialize In This Condition (14)
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Director, Pediatric and Young Adult Cancer Health Outcomes Research Center, Dana-Farber Cancer Institute
Associate Professor of Pediatrics, Harvard Medical School